1 0 0 0 OA 医賸 3巻附1巻
- 著者
- 櫟蔭拙者 著
- 出版者
- 英屋文藏 [ほか9名]
- 巻号頁・発行日
- vol.[1], 1809
1 0 0 0 OA 田中芳男とホヤ―1882年執筆の稿本『保夜考ヲ讀ム』から
- 著者
- 西川 輝昭
- 出版者
- 日本動物分類学会
- 雑誌
- タクサ:日本動物分類学会誌 (ISSN:13422367)
- 巻号頁・発行日
- vol.51, pp.19-28, 2021-08-31 (Released:2021-08-31)
- 参考文献数
- 48
Baron Yoshio Tanaka (1838–1916), a famous historical researcher of natural history based in the “honzo-gaku” (traditional natural history) developed in the Edo Period in Japan, established himself as a talented and energetic higher governmental official in early modern Japan, establishing the National Museum. He also contributed much to the development of modern biological education by the compilation of wallcharts and translations of European and American textbooks into Japanese, and improved understanding of agricultural and fisheries products. He is therefore regarded to have bridged the gap between pre-modern and modern approaches in biology (especially botany), although his influence in the understanding of ascidians has been overlooked. However, a hand-written and previously unknown manuscript on this animal group by Tanaka (dated 1882), translated here into modern Japanese with detailed explanatory notes, included references to dissected museum specimens, evidence of Tanaka’s modern approach, since dissection and museum-deposition of specimens had not been practiced in “honzo-gaku”. The only cited western article in the manuscript, entitled “Cuvier’s molluscs”, was identified as Deshayes’ molluscan volume [completed in 1845 and including good figures of ascidian anatomy] included in the third edition of Cuvier’s “Le Règne Animal”, issued between 1836 and 1849. However, Tanaka made no reference to Lankester’s “urochordate” concept, published in 1877, and left no detailed figures of ascidian anatomy, necessary for modern taxonomy. In fact, the modern taxonomy of Japanese ascidians was begun in 1882 by foreign taxonomists, to be followed soon after by a Japanese researcher, Dr. Asajiro Oka. However, these endeavors did not avail themselves of Tanaka’s museum specimens, which were possibly unavailable even then, due to irregular museum deposition practice. It is clear that the gap between pre-modern and modern practices, was very significant in the case of ascidians.
1 0 0 0 OA 函館高専学生の体格・体脂肪率の23年間の推移
- 著者
- 浦田 清 清野 國安
- 出版者
- 独立行政法人国立高等専門学校機構 函館工業高等専門学校
- 雑誌
- 函館工業高等専門学校紀要 (ISSN:02865491)
- 巻号頁・発行日
- vol.53, pp.116-123, 2019 (Released:2019-02-08)
- 参考文献数
- 10
The purpose of this study was to investigate the 23 years change of physique and body fat on the students of National Institute of Technology, Hakodate College (N.I.T.H.C.). In the change of height, a significant regression coefficients were obtained except for the 5th grade, and tend to decrease for 23 years. In the change of weight, significant regression coefficients were obtained for 1st, 2nd and 3rd grade, and tend to decrease for 23 years. In the change of body fat, significant regression coefficients were obtained for the 1st, 3rd and 4th grade, and tend to increase for 23 years.
1 0 0 0 OA 日本基礎心理学会第40回大会シンポジウム1 基礎心理学研究における深層学習の役割
1 0 0 0 OA 石橋山義兵白旗 5巻
1 0 0 0 OA 石橋山合戦 3巻
青本、3冊合1冊、柱題「石はし山、いしはし山」、画工名無記。(1)初印系は「根元石橋山」の題で山本が刊行、宝暦13年(1763)とみられ、大東急記念文庫本「根元石橋山」が該当。(2)同じ版木を西宮が求めて「石橋山无動源氏」の題で販売したのは題簽の意匠から「卯年」と判り「寛政七乙卯年(1795)」と推定される。大東急記念文庫本「石橋山无動源氏」が該当。(3)題名は初印本と同じで題簽の初印の意匠上下の福良雀部分を青海波と一兎に、冊次下の商標の「丸に山」を「丸に十」に入れ木で修正した東洋文庫岩崎文庫本「根元石橋山」がある。(2)と(3)の関係は未解明である。当館本の題名「石橋山合戦」は任意の後補書題であり、本文の商標欠なので、改題系(2)か(3)の題簽欠ということになる。
- 著者
- 小野 禾韻厘
- 出版者
- 松山大学総合研究所
- 雑誌
- 松山大学論集 = MATSUYAMA UNIVERSITY REVIEW (ISSN:09163298)
- 巻号頁・発行日
- vol.31, no.1, pp.227-256, 2019-04-01
1 0 0 0 OA 出産後のドケルバン病・手根管症候群に対する当帰芍薬散での治療経験
- 著者
- 福嶋 裕造 塩田 敦子 多久島 康司 藤田 良介 戸田 稔子 船越 多恵 三明 淳一郎
- 出版者
- 一般社団法人 日本東洋医学会
- 雑誌
- 日本東洋医学雑誌 (ISSN:02874857)
- 巻号頁・発行日
- vol.70, no.3, pp.236-239, 2019 (Released:2020-02-05)
- 参考文献数
- 8
- 被引用文献数
- 1
ドケルバン病や手根管症候群は産後に多く起こる問題である。妊娠の影響でホルモンのバランスが崩れ腱鞘炎になりやすい上に出生児の世話で手をよく使うために症状が出やすいと考えられる。今回,出産後にこれらの症状を訴えた4例を報告する。症例は全例女性で,33歳から39歳であり,全例出産後に授乳を行っていた。診断はドケルバン病が1例,手根管症候群が2例,ドケルバン病と手根管症候群の合併が1例であった。全例に当帰芍薬散を投与した。全例に疼痛が軽快または消失して,手根管症候群の軽度のしびれは残存している。授乳中の治療中に使用できる薬剤は限られるが,当帰芍薬散は安全に使用できて有効な薬剤であると考えられた。
1 0 0 0 OA Clinical Efficacy and Pharmacokinetics of Levothyroxine Suppository in Patients with Hypothyroidism
- 著者
- Yasuharu Kashiwagura Shinya Uchida Shimako Tanaka Hiroshi Watanabe Masahiro Masuzawa Tadanori Sasaki Noriyuki Namiki
- 出版者
- The Pharmaceutical Society of Japan
- 雑誌
- Biological and Pharmaceutical Bulletin (ISSN:09186158)
- 巻号頁・発行日
- vol.37, no.4, pp.666-670, 2014-04-01 (Released:2014-04-01)
- 参考文献数
- 12
- 被引用文献数
- 5 11
This study aimed to elucidate the clinical efficacy and pharmacokinetics of levothyroxine (LT4) suppository, thus, we examined the pharmacokinetics of thyroxine (T4) after the administration of the suppository in thyroidectomized rats and examined dose and the levels of free T4 (FT4) in patients with hypothyroidism receiving suppositories. Thyroidectomized rats were administered with LT4 solution and LT4 suppository (30 µg/kg), and plasma T4 concentrations were measured using LC/MS. The AUC0–168 of T4 after rectal administration of the LT4 suppository was 64% lower than these values after oral administration. To evaluate clinical effect of LT4 suppository, we enrolled 6 Japanese patients with hypothyroidism (2 men and 4 women; age, 68.2±13.5 years) who were administered LT4 suppository at Kameda Medical Center from 2007 to 2013 in this case series. The FT4 level during the administration of suppositories was significantly lower than that during the administration of tablets (0.657±0.183 ng/dL vs. 1.25±0.51 ng/dL, p=0.034). The FT4/dose ratio for the suppository was significantly 44% lower than that for the tablet (p=0.020). In conclusion, although the bioavailability of LT4 is lower after administration of the suppository than after the oral formulation, it was suggested that T4 levels can be maintained in patients with hypothyroidism by administering LT4 suppositories at a dose 1.8 times higher than that of the tablet. Thus, the administration of LT4 suppository can be an alternative for treatment with oral medication in clinical practice.